Departure of U.S. Contractors Poses Problems for Afghan Military

It is not just U.S. troops who are with­draw­ing from Afghanistan. Thou­sands of pri­vate con­trac­tors — who help keep the Afghan Air Force fly­ing, among oth­er tasks — are leav­ing as well.



Tags: design TT Mod­ell­bahn TT H0 N schal­ten mod­elleisen­bahn bahn spiele­max preise 

Ein Reichsmarschall von Adolf Hitler hatte auch Märklin Modelleisenbahn Modelle > read more

Vaccine Maker Earned Record Profits but Delivered Disappointment in Return

Emer­gent BioSo­lu­tions was award­ed a $628 mil­lion fed­er­al con­tract with no com­pet­i­tive bid­ding. Top exec­u­tives received big bonus­es while fac­to­ries most­ly sat idle and tens of mil­lions of Covid-19 dos­es were thrown away. Tags: design […]



Tags: design TT Mod­ell­bahn TT H0 N schal­ten mod­elleisen­bahn bahn spiele­max preise 

Ein Reichsmarschall von Adolf Hitler hatte auch Märklin Modelleisenbahn Modelle > read more

100 Million Vaccine Doses Held Up Over Contamination Concerns, Emergent Reveals

Exec­u­tives from Emer­gent, which ruined mil­lions of coro­n­avirus vac­cine dos­es, divulged to Con­gress the scope of the reg­u­la­to­ry review of its trou­bled Bal­ti­more plant.

Emergent, Which Ruined Vaccine Doses, Gave Its Top Executives Bonuses

The gov­ern­ment has so far paid Emer­gent BioSo­lu­tions $271 mil­lion, even though Amer­i­can reg­u­la­tors have yet to clear a sin­gle dose of vac­cine pro­duced at its man­u­fac­tur­ing plant in Baltimore.

Troubled Vaccine Maker and Its Founder Gave $2 Million in Political Donations

Emer­gent BioSo­lu­tions faces scruti­ny in Con­gress for ruin­ing Covid-19 vac­cines and secur­ing lucra­tive fed­er­al con­tracts. Exec­u­tives will appear before some law­mak­ers who ben­e­fit­ed from the company’s spending.

Vaccines Made at Troubled Baltimore Plant Were Shipped to Canada and Mexico

The Biden admin­is­tra­tion said it did not know of man­u­fac­tur­ing prob­lems at the Emer­gent fac­to­ry when it approved ship­ping mil­lions of dos­es of AstraZeneca’s vac­cine. The com­pa­ny says the dos­es were safe.

The Covid-19 Plasma Boom Is Over. What Did We Learn From It?

The U.S. gov­ern­ment invest­ed $800 mil­lion in plas­ma when the coun­try was des­per­ate for Covid-19 treat­ments. A year lat­er, the pro­gram has fizzled.

Top Official Warned That Covid Vaccine Plant Had to Be ‘Monitored Closely’

An Oper­a­tion Warp Speed report last June flagged staffing and qual­i­ty con­trol con­cerns at Emer­gent BioSo­lu­tions’ fac­to­ry in Bal­ti­more. The trou­bled plant recent­ly had to throw out up to 15 mil­lion doses.

U.S. Bet on Covid Vaccine Manufacturer Even as Problems Mounted

The Bal­ti­more plant that recent­ly had to scrap up to 15 mil­lion ruined dos­es had flout­ed rules and down­played errors, accord­ing to inter­nal audits, ex-employ­ees and clients. Oth­er dos­es had to be scrapped last year.

U.S. Bet Big on Covid Vaccine Manufacturer Even as Problems Mounted

The Bal­ti­more plant that recent­ly had to scrap up to 15 mil­lion ruined dos­es had flout­ed rules and down­played errors, accord­ing to inter­nal audits, ex-employ­ees and clients. Oth­er dos­es had to be scrapped last year.

Coronavirus Vaccine ‘Fiasco’ Damages Europe’s Credibility

The Euro­pean Union’s fail­ure to secure ade­quate vac­cine sup­plies, fol­lowed by an export ban, has dent­ed the rep­u­ta­tion of the bloc’s lead­ers. It may also hurt their abil­i­ty to act in oth­er areas.